Taj Pharma is one of the leading generic pharmaceutical company in India. We hold top positions in different established markets and gradually building a strong presence in many emerging generics markets. We have eight manufacturing sites under flagship in India to support our market standing. Today, we market more than 100+ branded and 500+ generics compositions to consumers in more than 28 countries and territories across the globe. Our products cover a vast array of therapeutic categories, and we offer an extensive range of dosage forms and delivery systems including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids and high-potency products.

Today, we market more than 100+ branded and 500+ generics compositions to consumers in more than 28 countries and territories across the globe. Our products cover a vast array of therapeutic categories, and we offer an extensive range of dosage forms and delivery systems including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids and high-potency products.

At Taj Pharma, we are always ready to meet the challenges of the dynamic global pharmaceutical industry with its numerous and wide-ranging issues – from complex research, development and regulatory conditions to rapidly changing consumer demands.

Our Generics portfolio offers over 600+ products in the major therapeutic areas of gastro-intestinal, cardiovascular, pain management, oncology, anti-infectives, paediatrics and dermatology. Brands like Alzocum®, Benacof, Wallbrurate®, Coversec, Cadrol, Humogen and Merokem enjoy leadership positions in several key markets, including India, Russia & other CIS countries.

We have capitalized on every opportunity to bring our high-quality products to more people around the globe. A synchronized supply chain that leverages our strong product development capabilities, state-of-the-art manufacturing setups and vertical integration with our own APIs has created a creditable track record of successful launches.

Our generics offerings deliver quality at cost-effective prices in the semi-regulated markets of the South America, North America, Africa, Balkan countries & Asian countries.

Our Generics portfolio offers over 600+ products in the major therapeutic areas of gastro-intestinal, cardiovascular, pain management, oncology, anti-infectives, paediatrics and dermatology. Brands like Alzocum®, Benacof, Wallbrurate®, Coversec, Cadrol, Humogen and Merokem enjoy leadership positions in several key markets, including India, Russia & other CIS countries.

Our deep customer relationships, quality medicines and consistently delivered promise make us a trusted brand across the launched markets.

We have capitalized on every opportunity to bring our high-quality products to more people around the globe. A synchronized supply chain that leverages our strong product development capabilities, state-of-the-art manufacturing setups and vertical integration with our own APIs has created a creditable track record of successful launches.

Our generics offerings deliver quality at cost-effective prices in the semi-regulated markets of the South America, North America, Africa, Balkan countries & Asian countries.

Our Generics portfolio offers over 600+ products in the major therapeutic areas of gastro-intestinal, cardiovascular, pain management, oncology, anti-infectives, paediatrics and dermatology. Brands like Alzocum®, Benacof, Wallbrurate®, Coversec, Cadrol, Humogen and Merokem enjoy leadership positions in several key markets, including India, Russia & other CIS countries.

Our deep customer relationships, quality medicines and consistently delivered promise make us a trusted brand across the launched markets.

We have capitalized on every opportunity to bring our high-quality products to more people around the globe. A synchronized supply chain that leverages our strong product development capabilities, state-of-the-art manufacturing setups and vertical integration with our own APIs has created a creditable track record of successful launches.

Our generics offerings deliver quality at cost-effective prices in the semi-regulated markets of the South America, North America, Africa, Balkan countries & Asian